Most sourcing conversations about private label toothpaste start with price and minimum order quantity. For the European market that ordering is backwards, because the constraint that actually decides your launch date is not the factory — it is the paperwork that has to exist before the product is allowed on a shelf.
Oral care is a cosmetic in the EU, and that word carries obligations
Under Regulation (EC) No 1223/2009, toothpaste, mouthwash and breath sprays are cosmetic products. That classification is good news in one sense: there is no pre-market approval to wait for, no authorisation dossier sitting in a queue. But it replaces approval with responsibility, and the responsibility is placed on a named legal person inside the EU rather than on the factory that made the goods.
Three things must be true before the product can be made available on the EU market. A Responsible Person must be designated. A Product Information File must exist and be kept at an address in the EU. And the product must be notified through the Cosmetic Products Notification Portal.
The Responsible Person is not your factory
This is the point most first-time importers get wrong, and it is worth being blunt about: a manufacturer in China cannot be your Responsible Person. The role requires establishment in the EU. In practice it will be your own European company if you have one, your importer, or a specialist service provider you appoint in writing.
The Responsible Person carries real exposure. They are accountable for the product's compliance, they must keep the PIF accessible to authorities for ten years after the last batch was placed on the market, and they are the point of contact when a national authority asks questions or when a serious undesirable effect has to be reported. Appointing one is not a formality you handle after the container ships. It is a decision that should be made before you approve the formula, because the Responsible Person will want a say in what is in it.
What actually goes into a Product Information File
The PIF is the evidence file behind the product. It has to contain a description of the product, the cosmetic product safety report, a description of the manufacturing method with a statement of compliance with Good Manufacturing Practice, proof of the claimed effect where the nature of the claim justifies it, and data on any animal testing performed.
The heart of it is the safety report, and that has two halves. Part A is the safety information: the quantitative and qualitative formula, the physicochemical and microbiological specifications, impurity and packaging data, exposure to the product and to the substances in it, and the toxicological profile of each ingredient. Part B is the assessment itself, and it must be signed by a person holding a qualification in pharmacy, medicine, toxicology or a similar discipline. Part B is not something a factory produces. Part A is largely built from what the factory gives you.
The exact list to request from your manufacturer
If you take one practical thing from this article, take this list. Ask for it early, in writing, and treat a vague answer as information in itself:
- Full quantitative formula with INCI names and CAS numbers, not a marketing ingredient list
- Specifications and certificates of analysis for the finished product and for the raw materials
- Microbiological specification and challenge test results, which matter more than people expect for pastes and rinses
- Stability data and the shelf life it supports, with the storage conditions it was tested under
- Compatibility data between the formula and the actual packaging you intend to use, not a generic tube
- A GMP statement, ideally underpinned by ISO 22716 certification of the plant
- Confirmation that no ingredient appears on the Annex II prohibited list, and that any Annex III restricted substance is within its limit for oral products. Note that substances classified as carcinogenic, mutagenic or toxic for reproduction under CLP are prohibited in cosmetics by default — the classifications are searchable in ECHA's C&L inventory
- Fluoride content stated precisely if the product contains fluoride, because the limit and the mandatory warning depend on it
- Declaration on animal testing consistent with the EU ban
- Nanomaterial declaration, which is a yes-or-no question but has to be answered explicitly
A factory that has genuinely exported to Europe will recognise this list and produce most of it without drama. One that has not will send you a certificate of analysis and hope it passes. That difference is worth discovering during sourcing rather than during your safety assessment.
Fluoride, and why the number matters
Fluoride is permitted in oral care within a defined limit, and the specific figure drives your labelling. Above a certain concentration a warning about children's use becomes mandatory, and the exact wording is prescribed rather than left to your copywriter. If you plan a children's line, this is the first thing to settle with the factory, because it determines both the formula and what has to be printed on the tube.
This is also where a fluoride-free positioning gets commercially interesting. It removes the warning requirement entirely, and for a brand aimed at parents that can be the point rather than a compromise. What it does not remove is anything else on the list above.
If you also sell in the United States, the same tube changes category
This catches brands that plan a transatlantic launch off one production run. In the EU a fluoride toothpaste is a cosmetic. In the United States it is an over-the-counter drug under the anticaries monograph, which brings a Drug Facts panel, an NDC listing and a different labelling regime with it. The formula can be identical; the paperwork and the artwork are not. The FDA's guidance on toothpaste is the starting point if that market is on your roadmap.
Fluoride-free products avoid the drug classification in the US and stay cosmetic on both sides of the Atlantic. That is a formulation decision with a regulatory consequence, which is why it belongs in the sourcing conversation rather than the marketing one.
Labelling is where good sourcing goes to die
The pack has to carry the name and address of the Responsible Person, the country of origin for imported goods, the nominal content, the date of minimum durability or the period-after-opening symbol, precautions for use, the batch number, the product function where it is not obvious, and the ingredient list in INCI order. It has to be in the language of every market where you sell.
None of that is difficult, but it consumes artwork space that brand designers reliably underestimate, and it is discovered late. If your factory is designing the packaging, give them the mandatory elements before the layout is approved rather than after.
CPNP notification, and the order of operations
The notification itself is done by the Responsible Person through the CPNP portal, and it must be submitted before the product is placed on the market. It covers the product category and name, the Responsible Person's details, the country of origin, the market where it will be placed, the frame formulation or product formula, and the labelling with a photograph of the packaging where reasonably legible.
The sequence that works is: appoint the Responsible Person, agree the formula and packaging with the factory, assemble the PIF, have the safety assessment completed and signed, finalise the artwork, notify on CPNP, then ship. The sequence that causes delay is doing any of it after the goods have already left.
What this means for your timeline
The factory lead time is only one leg of your schedule, and often not the longest one. Assembling a PIF and getting a safety assessment signed takes time that runs in parallel with production only if you start it in parallel. A brand that treats compliance as a shipping formality discovers a gap of weeks between goods arriving and goods being sellable.
If you are planning a first EU launch, the useful question to ask a manufacturer is not "what is your MOQ" but "show me the technical dossier you supplied for your last European customer." The answer tells you what your next three months look like.
This article explains a regulatory framework in general terms and is not legal advice. Requirements are interpreted and enforced by national authorities, and your Responsible Person or regulatory consultant should confirm what applies to your specific product and markets.